Cleared Traditional

K221696 - ReWalk P6.0 (FDA 510(k) Clearance)

Mar 2023
Decision
265d
Days
Class 2
Risk

K221696 is an FDA 510(k) clearance for the ReWalk P6.0. This device is classified as a Powered Exoskeleton (Class II - Special Controls, product code PHL).

Submitted by Re Walk Robotics , Ltd. (Yokneam, IL). The FDA issued a Cleared decision on March 2, 2023, 265 days after receiving the submission on June 10, 2022.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 890.3480. A Powered Exoskeleton Is A Prescription Device That Is Composed Of An External, Powered, Motorized Orthosis That Is Placed Over A Person's Paralyzed Or Weakened Lower Extremity Limb(s) For Medical Purposes..

Submission Details

510(k) Number K221696 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 10, 2022
Decision Date March 02, 2023
Days to Decision 265 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code PHL - Powered Exoskeleton
Device Class Class II - Special Controls
CFR Regulation 21 CFR 890.3480
Definition A Powered Exoskeleton Is A Prescription Device That Is Composed Of An External, Powered, Motorized Orthosis That Is Placed Over A Person's Paralyzed Or Weakened Lower Extremity Limb(s) For Medical Purposes.